HIF1A and pulmonary arterial hypertension: Furthermore, in MCT-induced PAH-like rats, HIF-1α antagonists helped alleviate pulmonary vascular remodeling and lipid accumulation, but supplementation of recombinant CD36 affected the therapeutic effect.